120
Participants
Start Date
January 17, 2020
Primary Completion Date
July 1, 2022
Study Completion Date
December 15, 2022
Nicardipine
In the event where SBP values are above the randomly assigned target, intravenous nicardipine will be initiated at 2.5 mg/hr to lower the SBP. If SBP is still not reduced to below assigned target after 15 minutes, nicardipine dose will be increased by 2.5 mg/hr every 15 minutes until the target SBP or a maximum dose of 15 mg/hr is reached.
Labetalol
If SBP is above target despite maximum nicardipine infusion for 30 minutes, 10-20 mg of intravenous labetalol will be added every 15 minutes.
Hydralazine
If SBP remains unresponsive for 1 hr despite the use of maximum doses of nicardipine and labetalol, a Hydralazine will be added at the treating physician's discretion. Incidence of the latter scenario is anticipated to be exceedingly rare.
Vanderbilt University Medical Center, Nashville
University of Cincinnati, Cincinnati
Hartford Healthcare, Hartford
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Vanderbilt University Medical Center
OTHER
University of Cincinnati
OTHER